Top Markets
Coin of the day
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
Rangering i aksjer #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Aksjekurs
$2.26
Sist synkronisert: 2026-08-21
Markedsverdi
$81.55M
Endring (1 dag)
-0.86%
Endring (1 år)
-18.45%
Land
JP
Handel Stella Pharma Corporation (4888)

Kategori

P/B-forhold for Stella Pharma Corporation (4888)
P/B-forhold per 2026 TTM: 0
Ifølge Stella Pharma Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Stella Pharma Corporation fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH